IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment

Yandong Shen, Kyle Crassini, Narjis Fatima, Michael O’Dwyer, Michael O’Neill, Richard I. Christopherson, Stephen P. Mulligan, O. Giles Best

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science